Funded Tech Companies
Cyllene Therapeutics
Wondering who invested in Cyllene Therapeutics? GordonMD Global Investments, Bpifrance and Andera Partners put venture money into this biopharmaceutical company.
Company Overview
Company Name
Cyllene Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
13 rue Watt
Paris, 75013
France
Paris, 75013
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Cyllene Therapeutics is a French biotechnology company that is pioneering a new approach called pinpoint gene therapy. Developing next generation DNA medicines to provide safe, efficacious, and affordable therapies to patients with severe localized chronic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/7/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Philippe Chambon
Chief Marketing Officer
Cornelia Molkenteller
Chief Operating Officer
Samuel Salot
Chief Scientific Officer
Alberto Epstein
Co-Founder
Pierre Denys
Co-Founder
François Giuliano
Co-Founder
Charles Joussain
VP - Bus. Development
Mikael Contrastin
VP - R & D
Teddy Jégu
VP - R & D
Astrid Valles-Sanchez
Company Investors
- GordonMD Global Investments
- Bpifrance
- Andera Partners
- M Ventures
- LaMond Family Medicine
- Bpifrance (Benoît Barteau)
- Andera Partners (Raphaël Wisniewski)
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs